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Brachyury+ mesodermal cell population with purity over 79% was obtained from differentiat-
ing brachyury embryonic stem cells (ESC) generated with brachyury promoter driven
enhanced green fluorescent protein and puromycin-N-acetyltransferase. A comprehensive tran-
scriptomic analysis of brachyury+ cells enriched with puromycin application from 6-day-old
embryoid bodies (EBs), 6-day-old control EBs and undifferentiated ESCs led to identification
of 1573 uniquely up-regulated and 1549 uniquely down-regulated transcripts in brachyury+
cells. Furthermore, transcripts up-regulated in brachyury+ cells have overrepresented the Gene
Ontology annotations (cell differentiation, blood vessel morphogenesis, striated muscle devel-
opment, placenta development and cell motility) and Kyoto Encyclopedia of Genes and
Genomes pathway annotations (mitogen-activated protein kinase signaling and transforming
growth factor beta signaling). Transcripts representing Larp2 and Ankrd34b are notably up-
regulated in brachyury+ cells. Knockdown of Larp2 resulted in a significantly down-regulation
BMP-2 expression, and knockdown of Ankrd34b resulted in alteration of NF-H, PPARc and
PECAM1 expression. The elucidation of transcriptomic signatures of ESCs-derived brachyury+
cells will contribute toward defining the genetic and cellular identities of presumptive meso-
dermal cells. Furthermore, there is a possible involvement of Larp2 in the regulation of the late
mesodermal marker BMP-2. Ankrd34b might be a positive regulator of neurogenesis and a
negative regulator of adipogenesis.
Introduction
During early embryonic development, the mesoder-
mal cells become sequentially determined to more
precisely defined cell fates and give rise to a diverse
array of functional somatic cell types including mus-
cles, heart, vasculature, blood, kidney, gonads, dermis
and cartilage. Understanding of the differentiation
process by which mesodermal cells are patterned into
diverse somatic cells demands an in-depth analysis of
the endogenous signaling cascades and transcription
factor networks (Willems & Leyns 2008). Till now,
this fascinating puzzle is not yet solved, because isola-
tion of pure mesodermal cells from early-stage
embryos in sufficient quantities was not feasible
because of technical limitations, and hence the func-
tional genomics of the mesodermal cells has not yet
been successfully explored. This has caused a hin-
drance in our understanding on the patterning of
mesoderm into its specific lineages and an impedance
to the embryonic ⁄ induced pluripotent stem cell-based
cell replacement therapy to treat several degenerative
diseases. Embryonic stem cells (ESCs) have been
proven to be a promising tool to study the early
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embryonic development in a more physiological con-
text in vitro because of their versatility over other
conventional systems (Doss et al. 2004; Gadue et al.
2005; Winkler et al. 2005).
In mouse embryo, mesoderm is generated from
the epiblast through the process of gastrulation that is
initiated at approximately day 6.5 of gestation (Tam
& Behringer 1997; Baron 2005). Brachyury (also
known as T) is considered to be one of the best
markers of early pan-mesoderm and is used widely in
the field of developmental biology to track the devel-
opment of this germ layer (Kispert & Hermann 1993;
Lacaud et al. 2004). It is expressed in all nascent
mesoderm and down-regulated as these cells undergo
patterning and specification into the derivative tissues
including skeletal muscle, cardiac muscle and connec-
tive tissues in addition to blood and endothelium
(Herrmann 1991; Kispert & Herrmann 1994).
To circumvent the practical difficulties in isolating
in vivo brachyury-expressing cells in sufficient quanti-
ties during embryonic development, we used ESC
model as an alternative approach. We established an
ESC-derived transgenic brachyury cell line expressing
bicistronically both puromycin-N-acetyltransferase
and enhanced green fluorescent protein (EGFP)
under the control of brachyury promoter with the
help of an IRES element. We further identified the
transcriptomic signatures of ESC-derived brachyury+
cells. Finally, we investigated the functional relevance
of two transcripts of unknown functions (TUFs),
La ribonucleoprotein domain family, member 2 (Larp2) and
ankyrin repeat domain 34B (Ankrd34b) in the differenti-
ating embryoid bodies (EBs) by siRNA-mediated
knockdown approaches.
Results
Isolation of brachyury+ cells from the transgenic
brachyury ESC line
The 4.5-kb brachyury promoter was isolated from
the BAC clone containing brachyury gene using the
recombineering approach as outlined in the scheme in
the Fig. S1. It was then subcloned in the ESC target-
ing construct pPuro IRES2 EGFP to get pTbrap Puro
IRES2 EGFP. The brachyury ESC line was generated
with the linearized pTbrap Puro IRES2 EGFP con-
struct by stable transfection. EBs, when generated
from the brachyury ESC clone applying the hanging
drop protocol and analyzed at regular time intervals,
showed the transient expression of brachyury tran-
scripts as shown by RT-PCR (see Fig. 1a). The ESCs
and EBs from this transgenic clone behaved faithfully
with the wild-type ES and EBs in terms of the
brachyury expression and other germ layer-specific
transcripts expression (data not shown). The brachyury
expression is distributed uniformly throughout the
EBs as evident from the EGFP expression in every EB
as analyzed using confocal microscopy (see Fig. 1b).
Fluorescence-activated cell sorting (FACS) analysis of
the EBs showed the same pattern of EGFP expression
(Fig. 1c) as that of brachyury mRNA expression
(Fig. 1a). Application of puromycin with the experi-
mental protocol outlined in Fig. 1d led to the enrich-
ment of brachyury+ cells in 6-day-old EBs up to 79%
(hereafter called ‘brachyury+ cells’), compared to 1.4%
in the puromycin-untreated control 6-day-old EBs
from the same preparation (hereafter called ‘control
EBs’) as analyzed by FACS (see Fig. 1e). Under the
same treatment regime, the wild-type EBs did not sur-
vive in puromycin selection implying the remaining
21% of the cells in the puromycin-treated EBs are
brachyury positive at the time of puromycin selection
which later down-regulated brachyury and hence
EGFP expression at the end of puromycin selection
protocol because of ongoing differentiation process.
This finding is in association with the in vivo findings
that the brachyury expression is very transient, and
these cells undergo differentiation very dynamically.
Furthermore, the enrichment of brachyury+ cells was
confirmed by immunohistochemistry for the coex-
pression of EGFP and brachyury (see Fig. 1f).
Differentially expressed transcriptome in
brachyury+ cells
Transcriptomic profiling of the undifferentiated trans-
genic brachyury ESCs (hereafter called ‘ESCs’),
brachyury+ cells and control EBs was carried out from
three biologically independent set of experiments
using the Affymetrix mouse MG 430 v2.0 3¢ oligonu-
cleotide microarrays (Affymetrix UK Ltd, High
Wycombe, UK). Raw expression results were Robust
Multi-array Average (RMA)-normalized (Irizarry et al.
2003). A parametric ANOVA (F-tests) and three pair-
wise comparisons using the least significant differences
(LSD) post hoc test have been carried out on the tran-
scriptome results obtained from ESCs, control EBs
and brachyury+ cells. The false discovery rate (FDR)
of the F-test-set has been calculated using the Benja-
mini–Hochberg procedure (Hochberg & Benjamini
1990). An ANOVA FDR-value <10)3 has been used to
identify and restrict the number of 10 090 probe sets
transcripts that were differentially expressed among the
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conditions day-0 undifferentiated ESCs, day-6 control
EBs and day-6 brachyury+ cells. Further filtering of
the transcripts with LSD post hoc P < 0.01 (in each of
conditions – in brachyury+ cells vs. ESCs as well as in
brachyury+ cells vs. day 6 control EBs), a fold change
cutoff of 2 and redundancies removal led to 3022
unique transcripts.
We verified the Affymetrix data by examining
the expression levels of four randomly chosen repre-
sentative genes namely Nanog, bone morphogenetic pro-
tein 2 (Bmp2), Sox17 and neurofilament H (Nefh) by
applying the quantitative real-time PCR (qPCR)
method. As indicated in Fig. S2, results from the
Affymetrix analyses clearly correspond to the results
obtained from qPCR. Among them, 1573 transcripts
were found to be up-regulated in brachyury+ cells
in comparison with at least one of the two control
population, brachyury+ ESCs, control EBs or both,
and 1549 transcripts were down-regulated compared
to both control populations as summarized in
GAPDH
Figure 1 Isolation of brachyury+ cells from transgenic brachyury embryonic stem cells (ESCs). (a) Semi-quantitative RT-PCR
analysis of the brachyury transcript expression in the ESCs and the embryoid bodies (EBs) from brachyury ESCs at daily intervals
(for primers and conditions see Table S5). (b) Confocal fluorescence microscopy of EGFP-labeled brachyury+ cells within the EBs
at day 3 to day 5 of differentiation (bar scale 50 lm). (c) Fluorescence-activated cell sorting (FACS) analysis of the EGFP-labeled
brachyury+ cells after dissociation of undifferentiated brachyury ESCs and differentiated EBs at daily intervals. Only the endoge-
nous EGFP+ cells were scored. For precise calculation of percentage of EGFP+ cells, density plot was used. (d) Scheme of the
experimental protocol used for the enrichment of brachyury+ cells. (e) FACS analysis of enriched brachyury+ cells in comparison
with the day 6 puromycin untreated control EBs. For precise calculation of percentage of EGFP+ cells, dot plot with FL3 channel
was used. No staining for FL3 channel was carried out. (f) Immunohistochemical staining of the enriched brachyury+ cells to dem-
onstrate the co-expression of their brachyury expression and EGFP. EGFP, enhanced green fluorescent protein.
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Fig. 2a. To be more specific, the transcripts up-reg-
ulated in brachyury+ cells were further categorized
on their differential expression level relative to either
of the control populations. There are 341 transcripts
up-regulated in brachyury+ cells in comparison with
both ESCs and control EBs, 215 transcripts up-regu-
lated in comparison with ESCs but down-regulated
in comparison with control EBs and 203 transcripts
up-regulated in comparison with control EBs but
down-regulated to ESCs. The remaining 814 tran-
scripts of the brachyury+ cells show up-regulation in
either one of the ESCs or control population but do
not show a twofold down-regulation in either of
these, as summarized in Fig. 2a. The basic gene
ontology’s (GO) overrepresented by up- and down-
regulated transcripts in brachyury+ cells are shown in
Fig. 2b. These transcripts were then further analyzed
applying the Database for Annotation, Visualization
and Integrated Discovery (DAVID) tool (Dennis
et al. 2003). As demonstrated, over 400 transcripts
were identified to be involved in transcriptional pro-
cesses (see Fig. 2b). Interestingly, over 400 transcripts
seem to be involved in the regulation of the devel-
opmental processes. Among them, 216 transcripts
were identified to be up-regulated in brachyury+
cells. Hierarchical clustering of these 216 up-regu-
lated genes associated with development is shown in
Fig. 2c.
Analysis of the genes differentially regulated in
brachyury+ cells
The transcripts up- or down-regulated in brachyury+
cells in comparison with at least one of brachyury
ESCs and control EBs are shown in Fig. S3a,b,
respectively, using heatmap and dendrogram views
of hierarchical clustering results. These transcripts
were further analyzed, categorized and listed as fol-
lows. The functional annotations overrepresented by
the transcripts up-regulated in brachyury+ cells are
listed in Table 1. Hierarchical clustering of
transcripts down-regulated in brachyury+ cells in
comparison with at least one of ESCs and control
6-day-old control EBs is shown in Fig. S3b. Inter-
estingly, GOs containing genes regulating apoptosis,
development, cell differentiation, cell death, tran-
scription and blood vessel morphogenesis are highly
enriched. The functional annotations overrepresented
by the transcripts down-regulated in brachyury+ cells
are listed in the Table 2. Similar to the up-regulated
genes, several down-regulated genes have been iden-
tified to be involved in developmental processes
such as Bmp4, Hand1, Hand2, Dkk1, Fgf15, Gata4,
Tbx2 and Gli2. The transcripts up-regulated in
brachyury+ cells in comparison with both ESCs and
control EBs were categorized with their functional
role as transcription factors and the transcripts
involved in development and are listed in Table S1,
respectively. The development-related transcription
factors and signal transducers up-regulated in brachy-
ury+ cells compared to ESCs but down-regulated in
comparison with control EBs are listed in Table S2.
The development-related transcription factors and
signal transducers up-regulated in brachyury+ cells
when compared to 6-day-old control EBs but
down-regulated in comparison with brachyury ESCs
are listed in Table S3. The transcripts of the brachy-
ury+ cells that show up-regulation in comparison
with one of the ESCs or control population but in
turn do not show a twofold down-regulation among
either of the control populations (i.e. ESCs or con-
trol EBs) are further categorized and listed in
Table S4 on the basis of their role in development
and as transcription factors.
Figure 2 Analysis of the differentially expressed genes in brachyury+ cells when compared to undifferentiated and 6-day-old
embryoid bodies (EBs) using DAVID analysis. (a) Pie diagram showing the distribution of genes with more than twofold up- or
down-regulation. A total of 3022 unique transcripts, among them, 1573 transcripts are up-regulated in brachyury+ cells in compar-
ison with at least one of the two control population, brachyury+ embryonic stem cells (ESCs), control EBs or both and 1549 tran-
scripts are down-regulated compared to both control populations (b) DAVID was used to obtain gene ontology biological
processes annotations. The bar chart shows the number of genes in the categories adhesion, cell cycle, cell death, cell–cell signaling,
cellular metabolism, development, stress response, signal transduction, transcription and transport separately for up-regulated and
down-regulated transcripts. (c) Hierarchical clustering of probe sets identified as up-regulated and associated with ‘developmental
processes’ in brachyury+ at least twofold higher compared to either ESCs, control EBs or both. Each transcript is represented by a
single row of colored boxes; each array is represented by a single column. Rectangles corresponding to intermediately expressed
transcripts are colored black, up-regulated transcripts are indicated with red of increasing intensity, and weakly expressed transcripts
with green of increasing intensity.
Transcriptome of brachyury+ (T) cells
 2010 The Authors Genes to Cells (2010) 15, 209–228
Journal compilation  2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.
213
Table 1 Functional annotations overrepresented by transcripts upregulated in brachyury+ cells in comparison with at least one of
either embryonic stem cells or control embryoid bodies
Category Term Count P-value
SP_PIR_KEYWORDS transcription 133 1.80E-19
SP_PIR_KEYWORDS zinc 157 2.30E-19
SP_PIR_KEYWORDS alternative splicing 187 2.70E-18
SP_PIR_KEYWORDS zinc-finger 132 3.10E-18
GOTERM_MF_ALL protein binding 395 4.20E-18
SP_PIR_KEYWORDS nucleotide-binding 134 5.10E-16
GOTERM_MF_ALL nucleic acid binding 315 1.40E-15
GOTERM_MF_ALL DNA binding 206 2.20E-13
GOTERM_BP_ALL cell differentiation 119 6.20E-13
GOTERM_BP_ALL development 216 8.50E-13
GOTERM_MF_ALL transcription regulator activity 140 5.70E-12
GOTERM_BP_ALL transcription, DNA-dependent 209 8.30E-11
GOTERM_BP_ALL transcription 218 2.00E-10
SP_PIR_KEYWORDS developmental protein 61 5.20E-10
GOTERM_BP_ALL cell death 77 7.00E-10
GOTERM_BP_ALL regulation of transcription 210 8.90E-10
GOTERM_BP_ALL apoptosis 70 1.30E-08
GOTERM_BP_ALL organ development 106 1.60E-07
SP_PIR_KEYWORDS differentiation 32 1.20E-06
GOTERM_BP_ALL intracellular signaling cascade 101 2.10E-06
GOTERM_MF_ALL sequence-specific DNA binding 49 2.60E-06
GOTERM_BP_ALL morphogenesis 98 5.20E-06
GOTERM_BP_ALL cell cycle arrest 13 1.10E-05
GOTERM_BP_ALL neuron differentiation 36 1.30E-05
GOTERM_BP_ALL cell cycle 71 1.90E-05
GOTERM_BP_ALL muscle development 21 2.30E-05
GOTERM_BP_ALL organ morphogenesis 58 3.80E-05
GOTERM_BP_ALL nervous system development 58 5.70E-05
GOTERM_BP_ALL regulation of cell differentiation 24 6.00E-05
GOTERM_MF_ALL protein kinase activity 67 7.30E-05
SP_PIR_KEYWORDS transmembrane 198 7.60E-05
INTERPRO_NAME Ras GTPase 27 9.00E-05
GOTERM_MF_ALL kinase activity 93 9.50E-05
SP_PIR_KEYWORDS rna-binding 37 1.70E-04
INTERPRO_NAME Small GTP-binding protein domain 26 1.70E-04
GOTERM_MF_ALL protein serine ⁄ threonine kinase activity 55 1.80E-04
INTERPRO_NAME Ras small GTPase, Rab type 24 1.80E-04
GOTERM_BP_ALL cell development 38 4.00E-04
GOTERM_BP_ALL regulation of development 26 5.90E-04
INTERPRO_NAME Zinc finger, C2H2-type 73 6.30E-04
GOTERM_BP_ALL regulation of cell proliferation 32 6.90E-04
GOTERM_BP_ALL cell motility 34 7.40E-04
GOTERM_BP_ALL blood vessel morphogenesis 21 8.60E-04
GOTERM_BP_ALL neuron development 26 9.60E-04
INTERPRO_NAME Basic leucine zipper 7 1.10E-03
GOTERM_BP_ALL vasculature development 23 1.20E-03
INTERPRO_NAME Ras small GTPase, Ras type 20 1.30E-03
GOTERM_BP_ALL ectoderm development 14 1.50E-03
SP_PIR_KEYWORDS cell adhesion 27 1.60E-03
SP_PIR_KEYWORDS cytoskeleton 26 1.70E-03
M X Doss et al.
Genes to Cells (2010) 15, 209–228  2010 The Authors
Journal compilation  2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.
214
Table 1 (Continued)
Category Term Count P-value
GOTERM_BP_ALL tissue development 27 1.90E-03
GOTERM_BP_ALL blood vessel development 22 2.20E-03
GOTERM_BP_ALL epidermis development 13 2.20E-03
SP_PIR_KEYWORDS leucine zipper 6 2.40E-03
GOTERM_BP_ALL axon guidance 13 2.50E-03
GOTERM_BP_ALL cell proliferation 41 2.60E-03
GOTERM_BP_ALL positive regulation of transcription 27 2.70E-03
GOTERM_BP_ALL embryonic development 33 4.80E-03
GOTERM_BP_ALL cell fate commitment 14 5.70E-03
GOTERM_BP_ALL striated muscle development 11 9.50E-03




GOTERM_BP_ALL interphase of mitotic cell cycle 9 1.10E-02
KEGG_PATHWAY MAPK SIGNALING PATHWAY 34 1.20E-02
GOTERM_BP_ALL axonogenesis 17 1.20E-02
GOTERM_BP_ALL muscle cell differentiation 7 1.20E-02




GOTERM_BP_ALL regulation of bone remodeling 6 1.40E-02
GOTERM_BP_ALL sexual reproduction 27 1.50E-02
GOTERM_BP_ALL negative regulation of programmed cell death 16 1.60E-02
KEGG_PATHWAY NEURODEGENERATIVE DISORDERS 8 1.70E-02
GOTERM_BP_ALL negative regulation of development 11 1.80E-02
GOTERM_BP_ALL positive regulation of apoptosis 18 1.90E-02
SP_PIR_KEYWORDS mitogen 6 1.90E-02
GOTERM_BP_ALL skeletal development 17 2.00E-02
GOTERM_BP_ALL cellular morphogenesis during differentiation 20 2.30E-02
KEGG_PATHWAY TGF-BETA SIGNALING PATHWAY 14 2.40E-02
GOTERM_MF_ALL MAP kinase phosphatase activity 4 2.40E-02
GOTERM_BP_ALL neuron fate commitment 5 2.50E-02
GOTERM_BP_ALL determination of adult life span 3 2.50E-02
GOTERM_BP_ALL reproduction 30 3.00E-02
GOTERM_BP_ALL embryonic morphogenesis 16 3.10E-02
GOTERM_BP_ALL DNA packaging 23 3.30E-02
GOTERM_BP_ALL regulation of ossification 5 4.30E-02
GOTERM_BP_ALL vasculogenesis 5 4.30E-02
GOTERM_BP_ALL myoblast differentiation 5 4.30E-02
GOTERM_BP_ALL ER-nuclear signaling pathway 4 4.30E-02
BIOCARTA p38 MAPK Signaling Pathway 8 4.40E-02
GOTERM_BP_ALL embryonic limb morphogenesis 8 4.60E-02
GOTERM_BP_ALL MAPKKK cascade 13 5.30E-02
BIOCARTA p53 Signaling Pathway 5 5.30E-02
GOTERM_BP_ALL skeletal muscle fiber development 6 5.60E-02
GOTERM_BP_ALL neuron migration 7 5.70E-02
GOTERM_BP_ALL tube development 13 5.90E-02
GOTERM_BP_ALL epidermis morphogenesis 7 7.50E-02
GOTERM_BP_ALL placenta development 4 7.70E-02
GOTERM_BP_ALL fibroblast proliferation 3 7.70E-02
INTERPRO_NAME POU homeobox 4 8.40E-02
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Table 1 (Continued)
Category Term Count P-value
GOTERM_BP_ALL enzyme linked receptor protein
signaling pathway
22 9.30E-02
KEGG_PATHWAY CELL CYCLE 14 9.80E-02
BIOCARTA Melanocyte Development and
Pigmentation Pathway
3 9.90E-02
MAPK, mitogen-activated protein kinase.
Table 2 Functional annotations overrepresented by transcripts downregulated in brachyury+ cells in comparison with both embry-
onic stem cells and control embryoid bodies
Category Term Count P
GOTERM_BP_ALL development 203 8.50E-13
GOTERM_MF_ALL protein binding 340 1.50E-12
GOTERM_CC_ALL intracellular 586 2.10E-12
GOTERM_BP_ALL metabolism 559 1.10E-11
GOTERM_CC_ALL intracellular organelle 503 3.00E-10
GOTERM_CC_ALL organelle 503 4.00E-10
GOTERM_BP_ALL organ morphogenesis 68 9.00E-10
GOTERM_BP_ALL organ development 105 5.20E-09
GOTERM_MF_ALL metal ion binding 263 7.90E-09
GOTERM_MF_ALL transferase activity 166 2.80E-08
GOTERM_MF_ALL binding 740 2.90E-08
GOTERM_BP_ALL regulation of biological process 283 3.50E-08
GOTERM_BP_ALL cell motility 41 3.40E-07
GOTERM_BP_ALL regulation of physiological process 256 7.00E-07
GOTERM_BP_ALL cellular morphogenesis 51 8.30E-07
GOTERM_BP_ALL regulation of cellular process 258 8.40E-07
GOTERM_MF_ALL phosphotransferase activity,
alcohol group as acceptor
76 1.10E-06
GOTERM_BP_ALL regulation of cellular physiological process 246 1.70E-06
GOTERM_BP_ALL protein modification 138 2.10E-06
GOTERM_MF_ALL kinase activity 92 2.50E-06
GOTERM_MF_ALL transferase activity, transferring
phosphorus-containing groups
101 4.60E-06
GOTERM_BP_ALL system development 62 4.90E-06
GOTERM_MF_ALL cation binding 232 5.10E-06
GOTERM_BP_ALL enzyme-linked receptor protein signaling pathway 34 5.40E-06
GOTERM_BP_ALL embryonic development 40 5.90E-06
GOTERM_MF_ALL adenyl nucleotide binding 117 7.40E-06
GOTERM_MF_ALL guanyl-nucleotide exchange factor activity 21 1.40E-05
GOTERM_MF_ALL small GTPase regulator activity 27 1.70E-05
GOTERM_BP_ALL negative regulation of biological process 76 1.90E-05
GOTERM_MF_ALL ATP binding 112 2.00E-05
GOTERM_MF_ALL protein serine ⁄ threonine kinase activity 53 4.20E-05
GOTERM_BP_ALL negative regulation of cellular process 70 4.50E-05
GOTERM_BP_ALL heart development 19 4.50E-05
UP_SEQ_FEATURE active site:Proton acceptor 59 6.70E-05
GOTERM_MF_ALL transition metal ion binding 167 7.20E-05
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Table 2 (Continued)
Category Term Count P
GOTERM_BP_ALL angiogenesis 20 7.30E-05
GOTERM_BP_ALL cell proliferation 44 7.90E-05
GOTERM_BP_ALL biosynthesis 105 9.30E-05
GOTERM_MF_ALL protein kinase activity 61 1.10E-04
GOTERM_BP_ALL cell differentiation 84 1.50E-04
GOTERM_MF_ALL oxidoreductase activity 73 1.50E-04
GOTERM_BP_ALL regulation of cell proliferation 32 1.80E-04
GOTERM_MF_ALL enzyme regulator activity 59 2.40E-04
GOTERM_BP_ALL cell adhesion 58 2.40E-04
GOTERM_BP_ALL cellular process 836 3.00E-04
UP_SEQ_FEATURE splice variant 185 3.00E-04
UP_SEQ_FEATURE binding site:ATP 48 3.00E-04
GOTERM_BP_ALL blood vessel morphogenesis 21 3.20E-04
GOTERM_BP_ALL blood vessel development 23 3.30E-04
GOTERM_BP_ALL neurogenesis 33 3.50E-04
KEGG_PATHWAY ECM-RECEPTOR INTERACTION 20 3.70E-04
GOTERM_BP_ALL cell development 36 3.80E-04
GOTERM_MF_ALL zinc ion binding 135 3.90E-04
GOTERM_BP_ALL intracellular signaling cascade 85 3.90E-04
GOTERM_BP_ALL vasculature development 23 4.30E-04
GOTERM_BP_ALL cellular morphogenesis during differentiation 24 4.40E-04
GOTERM_BP_ALL embryonic development (sensu Metazoa) 20 4.80E-04
GOTERM_BP_ALL transmembrane receptor protein
tyrosine kinase signaling pathway
20 5.30E-04
GOTERM_BP_ALL cell growth 17 5.30E-04
UP_SEQ_FEATURE nucleotide phosphate-binding region:ATP 70 6.10E-04
GOTERM_BP_ALL regulation of growth 18 8.10E-04
GOTERM_BP_ALL regulation of cell size 17 8.20E-04
GOTERM_BP_ALL protein amino acid phosphorylation 58 8.30E-04
GOTERM_BP_ALL tube development 17 1.00E-03
GOTERM_MF_ALL DNA binding 144 1.30E-03
GOTERM_MF_ALL protein-tyrosine kinase activity 35 1.40E-03
GOTERM_BP_ALL neuron development 24 1.60E-03
KEGG_PATHWAY FOCAL ADHESION 34 1.70E-03
GOTERM_BP_ALL skeletal development 19 1.80E-03
GOTERM_BP_ALL axonogenesis 18 2.50E-03
GOTERM_BP_ALL neuron morphogenesis during differentiation 20 2.90E-03
GOTERM_BP_ALL neurite morphogenesis 20 2.90E-03
GOTERM_BP_ALL endocytosis 20 3.40E-03
GOTERM_MF_ALL phosphoric monoester hydrolase activity 27 3.50E-03
UP_SEQ_FEATURE active site:Proton donor 17 3.80E-03
GOTERM_BP_ALL transcription 163 5.30E-03
GOTERM_BP_ALL cellular biosynthesis 85 5.70E-03
GOTERM_BP_ALL positive regulation of biological process 60 7.00E-03
GOTERM_BP_ALL monosaccharide catabolism 11 7.00E-03
UP_SEQ_FEATURE mutagenesis site 41 7.40E-03
GOTERM_BP_ALL organelle organization and biogenesis 79 9.00E-03
GOTERM_BP_ALL cell cycle 55 9.60E-03
GOTERM_CC_ALL envelope 38 1.10E-02
GOTERM_BP_ALL regulation of progression through cell cycle 34 1.20E-02
GOTERM_BP_ALL regulation of cell cycle 34 1.30E-02
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Promoter analysis of the transcripts up-regulated
in brachyury+ cells
To study the specific transcription regulatory mecha-
nisms related to brachyury+ cells, we obtained a list of
the genes up-regulated in the BMP-2+ cells and myo-
sin heavy chain a (a-MHC)+ cells as reference sets
from our previous published work (Doss et al.
2007a,b). We used these reference data sets to eliminate
the transcripts common to the late mesodermal ⁄ somatic
lineages. We carried out binding site analysis in the
promoters of the genes up-regulated specifically in the
brachyury+ cells (see Experimental procedures for
the detailed analysis). When scanned through all
the brachyury+ cell-specific transcription factors in
TRANSFAC (version 11.4) (BIOBASE GmbH,
Wolfenbu¨ttel, Germany) (Wingender et al. 1996) and
Jaspar (Sandelin et al. 2004) databases, two candidates
qualifying most of our criteria of analysis were filtered
out (see Fig. 3). Transfac motif M00242, peroxisome
proliferator-activated receptor a (PPARa), scored over
threshold 9.89 in 15 of 109 (13.8%) promoters of
the brachyury+-specific list. Transfac motif M00258,
interferon-sensitive response element (ISRE), scored
over threshold 10.63 in 23.9% of the promoters in
the brachyury+-specific genes. Target promoters of
PPARa in the brachyury+-specific list were from genes
AC158524.2, ACAA1B, ACTA1, ASPA, CDCP1,
GPATCH2, HIST1H1C, MPZL3, PRDM8, RB1,
SERPINB9B, SLC23A3, SLC7A6OS, SPRR2B and
TBX18. Target promoters of ISRE in the brachyury+-
specific list were from genes 5630401D24RIK,
B230120H23RIK, CDK9, CXCL10, EPS8L2, F3,
GBP1, GBP2, GPATCH2, H2-D1, H2-Q7, H2-Q8,
H2-T3, HHIPL2, HIST1H1C, IL1RAP, LATS2,
MARS, NEFM, PLK2, PPM1D, RIOK3, SER-
PINB9B, SLC23A3, SMC5 and ZBTB4.
Functional evaluation of Larp2 and Ankrd34b, two
TUFs specifically up-regulated in brachyury+ cells
The selection criteria for the functional analysis of the
TUFs for further investigation were as follows: (i)
their functions should be unknown so far at least for
their role in embryonic developmental context. (ii)
TUFs should be up-regulated with high fold change
compared to the ESCs and control EBs from the
Affymetrix data (see Fig. 4). (iii) TUFs should be
developmentally regulated in early embryos (see
Fig. 4b). (iv) TUFs should not have any information
other than their conserved domain contained in their
protein, if any.
Table 2 (Continued)
Category Term Count P
GOTERM_BP_ALL pattern specification 20 1.60E-02
GOTERM_BP_ALL physiological process 793 2.00E-02
GOTERM_CC_ALL extracellular space 163 2.70E-02
KEGG_PATHWAY TIGHT JUNCTION 19 3.10E-02
GOTERM_MF_ALL insulin-like growth factor binding 5 3.20E-02
GOTERM_BP_ALL positive regulation of cellular process 48 3.40E-02
GOTERM_CC_ALL nonmembrane-bound organelle 104 3.90E-02
GOTERM_CC_ALL intracellular nonmembrane-bound organelle 104 3.90E-02
GOTERM_BP_ALL regulation of signal transduction 19 4.50E-02
GOTERM_MF_ALL transferase activity, transferring glycosyl groups 21 4.70E-02
GOTERM_CC_ALL endomembrane system 28 4.90E-02
UP_SEQ_FEATURE transmembrane region 211 5.20E-02
GOTERM_BP_ALL cell division 18 6.00E-02
KEGG_PATHWAY AXON GUIDANCE 19 6.10E-02
GOTERM_BP_ALL tissue development 20 6.40E-02
GOTERM_BP_ALL positive regulation of development 9 6.60E-02
GOTERM_CC_ALL extracellular region 176 7.40E-02
GOTERM_BP_ALL mitotic cell cycle 18 8.00E-02
GOTERM_BP_ALL lung development 6 8.00E-02
GOTERM_BP_ALL mesoderm development 5 8.60E-02
GOTERM_BP_ALL circulation 8 8.70E-02
GOTERM_BP_ALL negative regulation of signal transduction 9 9.70E-02
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Accordingly, two TUFs, La ribonucleoprotein domain
family, member 2 (Larp2) (also known as
1700108L22Rik) and ankyrin repeat domain 34B
(Ankrd34b), were chosen after assessing fulfilment of
the above criteria (see Fig. 4). As demonstrated in
Fig. 4a, both transcripts are specifically up-regulated in
brachyury+ cells as well as in ES-derived BMP-2+ cells
which represents late mesodermal cells (Doss et al.
2007a) in contrast to functional cardiovascular cell
types such as cardiomyocytes (Doss et al. 2007b) and
contractile smooth muscle cells isolated from ESCs
(Potta et al. 2009). Larp2 (http://www.ncbi.nlm.
nih.gov/UniGene/clust.cgi?UGID=271837&TAXID
=10090&SEARCH=mm.46782) encodes for an
RNA-binding protein that is developmentally regu-
lated in early murine embryonic stages (http://www.
ncbi.nlm.nih.gov/sites/entrez?db=geo&cmd=search&
term=1700108L22Rik). This transcript is up-regu-
lated in preimplantation embryos. The function of
this gene has not yet been reported. LA domain codes
for a protein, which binds to RNA. Generally, the La
protein plays a role in the transcription of RNA poly-
merase III. It is most probably a transcription termi-
nation factor. Normally, it binds to the 3¢ termini of
virtually all nascent polymerase III transcripts. It is
associated with precursor forms of RNA polymerase
III transcripts including tRNA and 4.5S, 5S, 7S and
7-2 RNAs (by similarity).
Ankrd34b (UniGene Mm.213623, http://www.
ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Mm&CID
=213623) is normally expressed during embryonic




1435307_at&annot=Ankrd34b). The protein product
of this transcript contains conserved domains for
ankyrin-repeat domains. Ankyrin repeats mediate pro-
tein–protein interactions thereby modulating several
biological processes such as differentiation (Hortsch
et al. 2009). In this context, it has been demonstrated
that interaction of L1-type cell adhesion molecules
(CAMs) with ankyrins promotes neurogenesis (Horts-
ch et al. 2009). Ankyrins are also involved in the
neurogenesis in zebrafish (Diks et al. 2006) and
Xenopus neurogenesis (Lahaye et al. 2002).
Both transcripts were functionally evaluated by sys-
tematic ‘loss of function’ studies using the siRNA
knockdown approach. The relative mRNA expres-
sion levels of Nefh, brachyury, Bmp2, Sox17, Nanog,
Oct4, Myh6, PPARc, NF-H (also known as Nefh) and
PECAM1 were analyzed using qRT-PCR. Nefh,
brachyury, Bmp2 and Sox17 are the canonical germ
layer markers. Nanog and Oct4 are pluripotent ESCs
markers. Myh6, PPARc, NF-H and PECAM1 are
mesodermal-derived somatic cell markers for cardiac,
adipogeneic, neurogeneic and endothelial cells,
respectively. siRNA-transfected ESCs were moni-
tored for any morphological changes associated with
any differentiated cell types.
As shown in Fig. 5a–i, transfection by siRNA tar-
geted against Larp2 resulted in more than 50% sig-
nificant knockdown of Larp2 mRNA expression in
undifferentiated ESCs (d0) at 24 h post-transfection.
At 48-h post-transfection, the transfected undifferen-
tiated ESCs were used for differentiation applying
‘hanging drop’ protocol, and then total RNA was




Figure 3 Results of the promoter analysis. (a, c) Sequence logos of PPARA and interferon-sensitive response element (ISRE),
respectively. (b, d) The predicted target genes of PPARA and ISRE, respectively, sorted by the average of the three highest scor-
ing hits within the promoter of length 2000 bp. All the hits scoring over 6 in case of PPARA and 8 in case of ISRE are visualized
on the promoters.
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expected, the expression remained still down-regu-
lated in 1–9-day-old EBs (see Fig. 5a–ii) because of
siRNA knockdown. The expression of pluripotent
and germ layer representative genes was determined
using the qRT-PCR. As shown in Fig. 5b, the
BMP-2 expression level only at day 3 was signifi-
cantly down-regulated, compared to vehicle-treated
and untreated differentiated ESCs (see Fig. 5b). No
significant differences have been observed regarding
the expression of NF-H, brachyury and Sox17 (see
Fig. 5a) and pluripotent markers Oct4 and Nanog as
well as on the expression of the cardiomyocytes
markers such as GATA4, Nkx2.5 and a-MHC (data
not shown). As shown in Fig. 6a, transfection of the
brachyury+ cells with siRNA directed to Ankrd34b
resulted in a significant knockdown of the Ankrd34b
first detectable in 2-day-old EBs (80% inhibition of
the mRNA expression) and a complete knockdown
within the 3-day-old EBs compared to vehicle-
treated cells. Normal expression levels like in the
Figure 4 Expression levels of Larp2 and Ankrd34b in embryonic stem cells-derived mesodermal cells and somatic cells as well as dur-
ing mouse embryo development. (a) Expression levels of Larp2 and Ankrd34b that are specifically up-regulated in the mesodermal cells
[brachyury+ and BMP-2+ cells (Doss et al. 2007a) when compared to the ES-derived a-MHC+ cardiomyocytes (Doss et al. 2007b)
and Acta2+ smooth muscle cells (Potta et al. 2009). The arrays gene expression level of the undifferentiated ES cell lines (brachyury,
BMP-2, Acta2, and the a-MHC ES cell line) was set 100%. (b) Conserved LA domain contained in Larp2 (http://www.ncbi.nlm.
nih.gov/Structure/cdd/wrpsb.cgi?INPUT_TYPE=precalc&SEQUENCE=94536725&log$=ProtAccnMenu) and ankyrin repeat
domain 34B (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?INPUT_TYPE=precalc&SEQUENCE=172072675) as well
as the developmental stage-specific expression of Larp2 (http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=
Mm.46782) and Ankrd34b (http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.213623). MHC, myosin
heavy chain.
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vehicle-treated 4-day-old EBs have been observed in
the 4-day-old EBs generated from siRNA-treated
ESCs.
As demonstrated in Fig. 6b, the expression of
NF-H in EBs generated with siRNA-treated cells
was rapidly down-regulated in the 2-day-old EBs,
(a-i) (a-ii)
(b)
Figure 5 Effect of siRNAs directed to Larp2 on specific gene expression markers in embryonic stem cells (ESCs). (a) To assess
the efficiency of knockdown with siRNA against Larp2, transfection of ESCs cultured in culture petri-dishes (approximately 50%
confluence) with the appropriate siRNA (100 nM) was carried out. (i) RNA was collected 24 h after transfection and analyzed for
the expression level of Larp2. (ii) 48 h after transfection (day 0 as per the differentiation protocol), the siRNA-transfected ESCs
were used for making ‘hanging drop’ embryoid bodies (EBs). Upon isolation of total RNA, RT-PCR was carried out using the
respective primers shown in Table S5 (see Experimental procedures). As an internal loading control, PCRs were carried out using
the GAPDH primers (Table S5). Diagram summarizes densitometric analysis of three independent experiments (mean ± SD,
n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells). (b) Effect of siRNA on gene expression of germ layers-specific
genes in ESCs and EBs generated by the hanging drop protocol. After RNA isolation, the expression level was determined using
qRT-PCR (for more details see Materials). Experiments were carried out in triplicates (mean ± SD, n = 3, *P < 0.05 for the
siRNA-treated vs. untreated or vehicle-treated cells).
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compared to the high expression level of the NF-H
in undifferentiated and in 1-day- to 4-day-old EBs.
Furthermore, siRNA-treated ESCs and EBs showed
higher PPARc expression levels compared to the
respective vehicle-treated control ESC and EBs
(Fig. 6c). Also, the expression level of PECAM1 in
EBs generated from siRNA-treated cells remained sig-
nificantly higher between days 1 and 2 in comparison
with that in vehicle-treated EBs (see Fig. 6d). No dif-
ferences in mRNA expression levels of the pluripotent
marker genes (Oct4 and Nanog), mesodermal marker
genes (brachyury and BMP-2), cardiomyocytes and
endothelial marker genes between vehicle and siRNA-
treated cells could be observed (see Fig. S4).
Discussion
Analysis of the genes differentially regulated in
brachyury+ cells
Evidently, GOs associated with differentiation and
developmental processes as well as GOs associated
with an increased transcriptional activity are highly
enriched in genes up-regulated in the brachyury+
cells (Table 1). These results demonstrate the high
developmental capacity of brachyury+ cells. Obvi-
ously, GOs associated with transcripts regulating
apoptosis and cell death are also highly enriched. It is
well known that apoptosis is one of the key biological
(a) (b)
(d)(c)
Figure 6 Effect of siRNAs directed to ankyrin repeat domain 34B on specific gene expression markers in embryonic stem cells
(ESCs). (a) Transfection of ESCs cultured in culture Petri-dishes (approximately 50% confluence) with the appropriate siRNA
(100 nM) was carried out for 24 h. Upon isolation of total RNA, RT-PCR was carried out using the respective primers shown in
additional data file 9 (see Experimental procedures). As an internal loading control, PCR reactions were carried out using the
GAPDH primers (additional data file 9). Diagram summarizes densitometric analysis of three independent experiments
(mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells). (b, c, d) Effect of siRNA on gene expression
NFH expression PPARc and PECAM1, respectively, in ESCs and embryoid bodies generated by the hanging drop protocol. After
RNA isolation the expression level was determined by RT-PCR (for more details see Materials). Experiments were carried out in
triplicate (mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells).
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processes regulating specific organ development such
as cardiac and notochord development in vertebrates
(Martinsen 2005; Malikova et al. 2007). Interestingly,
transcripts associated with mitogen-activated protein
kinase (MAPK) SIGNALING Kyoto Encyclopedia
of Genes and Genomes (KEGG) PATHWAY, p38
MAPK BIOCARTA pathway and the MAPKKK
cascade GO biological process annotation (GO:
0000196) were found to be enriched in brachyury+
cells. The MAPK pathway is speculated to promote
inhibition of the self-renewal state of ESCs and is
involved in the development of the early mesoderm
differentiation. p38MAPK displays a large spectrum of
action from neurons to the mesodermal-derived
adipocytes [for review see (Binetruy et al. 2007)].
Transcripts associated with transforming growth factor
beta (TGFb) SIGNALING PATHWAY were also
found to be enriched in brachyury+ cells. TGFb
superfamily plays a key role for the induction of
mesoderm and endoderm (Shen 2007). From these
results, we might conclude that similarly to the in vivo
situation similar signaling pathways are identified to
be enriched in mesodermal brachyury+ cells. Interest-
ingly, Tbx6, Gm397, Lif, Follistatin and Wnt9a are
all up-regulated in brachyury+ cells in comparison
with both ESCs and control EBs (Table S1). In this
context, recently, it has been shown that Wnt signal-
ing and Tbx6, a T-box transcription factor, regulate
the presomitic mesoderm formation (Wittler et al.
2007; Dunty et al. 2008). Follistatin is a BMP-2
antagonist that is required for formation of the neural
plate and dorsal mesoderm (Khokha et al. 2005).
More recently, Gm397 has been identified to be a
predominant transcript in ESCs and renamed as
Zscan4c (Falco et al. 2007).
Promoter analysis of the transcripts upregulated in
brachyury+ cells
Transfac motifs M00242 peroxisome proliferator-acti-
vated receptor a (PPARa) and M00258 ISRE
showed several fold enrichment in the brachyury+-
specific list. Of these, ISRE is a strong inducer
of apoptosis acting through expression of caspase 8
(Casciano et al. 2004). This finding is in accordance
with our observation that the GOs containing genes
regulating apoptosis and cell death are also highly
enriched (see Table 1). PPARa belongs to the steroid
hormone receptor superfamily and is involved in
transcriptional regulation of genes regulating lipid
metabolism, cell proliferation and cell differentiation.
Recently, it has been shown that PPARa is involved
also in cardiomyocytes differentiation of murine ESCs
(Ding et al. 2007; Sharifpanah et al. 2008).
Functional evaluation of Larp2 and Ankrd34b, two
TUFs specifically up-regulated in brachyury+ cells
As Larp2 is up-regulated only in the mesodermal
brachyury and BMP-2 cell lineages (see Fig. 4a) and
also temporally and spatially regulated during mouse
embryonic development (see Fig. 4b), we assumed
that the rest of the protein motif(s) apart from the La
domain might play a role in the early developmental
stage. Together, our findings from siRNA-mediated
knockdown of Larp2 suggest that the Larp2 is posi-
tively involved in the regulation of BMP-2 expres-
sion. No differences in the morphology of the EBs
were observed (data not shown).
Interestingly, knockdown of Ankr34b led to signi-
ficant changes in the expression patterns of NF-H,
PPARc and PECAM1 on differentiation. NF-H is a
pan-ectodermal marker (Petzold et al. 2007). PPARc
is an adipogenic marker (Szabo et al. 2008) and
PECAM1, a haematopoietic and endothelial progeni-
tor cell-specific marker (Ross et al. 2008; Mariappan
et al. 2009).
To date, the role of Ankyrins in mesoderm-
derived adipocytes and endothelial progenitor cells
has not yet been reported. These results demonstrate
a negative regulatory effect of the Ankrd34b gene on
the expression of PPARc and PECAM1 and a posi-
tive regulatory role on the expression of NF-H.
These results suggest that Ankrd34b might be a posi-
tive regulator of the ectoderm-dependent neurogene-
sis and negative regulator of the mesoderm-dependent
adipogenesis and hematopoiesis. The present findings
support also the observation that Ankyrins are
involved in neurogenesis as observed as previously
described (Lahaye et al. 2002; Diks et al. 2006; Hortsch
et al. 2009). In conclusion, substantial attempts were
made to identify the complete transcriptome of the
brachyury+ mesodermal cells and to address the role
of two TUFs in terms of their possible role in regula-
tion of key genes involved in germ layer and somatic
cell development. The transcriptomic analysis of the
brachyury+ cells reported here defines the cellular and
genetic identities of the mesodermal cells for the first
time. Moreover, this will in turn significantly contrib-
ute to building lineage-specific transcriptomic atlas,
which will be of an immense application to the
developmental biologists and also for promoting the
protocols for the derivation of selective lineages
for the future cell replacement therapy. Finally, the
Transcriptome of brachyury+ (T) cells
 2010 The Authors Genes to Cells (2010) 15, 209–228
Journal compilation  2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.
223
identification of the TUFs by this approach in combi-
nation with ‘loss of function’ tools offers a new




All cell culture media, supplements, DNAse I and Super-
script II Reverse Transcriptase were purchased from Invitro-
gen (Karlsruhe, Germany). CGR8 ESCs were obtained from
European Collection of Cell Cultures (ECACC), catalogue
95011018 (Genoa, Italy). The Brachyury BAC clone (RP23-
376B1) and the ThermoScript Reverse Transcriptase were
obtained from Invitrogen. The BAC subcloning kit was
obtained from Gene Bridges, Dresden, Germany. Oligos for
subcloning of the brachyury promoter were purchased
from Metabion (Munich, Germany). Primary antibodies anti-
brachyury (catalogue ab20680) were from Abcam (Cambridge,
UK). Anti-mouse IgG1-AlexaFluor488 and anti-rabbit-
Ig-AlexaFluor647 were purchased from Molecular Probes
(Invitrogen GmbH, Karlsruhe, Germany). The TaqMan Gene
Expression Assays were purchased from Applied Biosystems
(Foster City, CA, USA). The QIAGEN’s RNeasy Total RNA
Isolation kit was obtained from Qiagen GmbH (Hilden,
Germany). The REDTaq ReadyMix was purchased by Sigma
(Munich, Germany).
ESC Culture and differentiation of EBs
CGR8 ESCs were cultured without feeder cells in Glasgow
Minimum Essential Medium supplemented with 10% FBS,
2 mM L-glutamine, 100 units ⁄mL leukemia inhibitory factor and
50 lM b-mercaptoethanol (b-ME) in 0.2% gelatine-coated flasks
as previously described (Gissel et al. 2005). To induce differenti-
ation, the hanging drop protocol was used as described earlier
(Gissel et al. 2005) using the differentiation medium containing
Iscove’s Modified Dulbecco’s Medium (IMDM), supplemented
with 20% FCS, 1% nonessential amino acids (v ⁄ v), 2 mM L-glu-
tamine and 100 lM b-ME). On day 2, the formed multicellular
aggregates (EBs) were transferred to suspension. On day 3, the
EBs were either treated with puromycin (5 lg ⁄ml) for the first
48 h and then with 2 lg ⁄ml for the subsequent 24 h or left
without treatment for 3 days. On day 6, the EGFP-fluorescing
EBs were trypsinized and used for either FACS analysis or RNA
extraction or immunohistochemistry.
Subcloning of brachyury promoter in the ESC-
targeting vector by BAC recombineering
Five-kilobase promoter region upstream of the translation initia-
tion site of the brachyury gene was subcloned from a BAC into
the ESC targeting construct pPuroIRES2 EGFP by a recombi-
neering approach as described in Fig. S1. Oligos with the fol-
lowing sequences GCT GAG TCT TCT CTG TCA TTT
AAA TTA GGC TCT GTC TCA GTT TGC CAT TCA
GAT CTT CAC AGC TTG TCT GTA AGC GGA TG and
CCT CCC GCC ACC CTC TCC ACC TTC CAG GAG
TCT TGA CTC CCT ACC CAA CAA GAT CTG CTC
TCC TGA GTA GGA CAA ATC were used to amplify the lin-
ear minimal vector containing ColE1 origin and Ampicillin
resistance cassette. The linear amplified product was electro-
porated into the Escherichia coli harboring the BAC and induced
to express Red ET proteins. The minimal vector containing the
brachyury promoter was positively selected with ampicillin.
Vector constructs and cell line generation
The basic ESC targeting construct pPuro IRES2 EGFP was
constructed as described previously (Doss et al. 2007a). The
minimal vector with brachyury promoter was digested with
Bgl II to release the brachyury promoter, which is then ligated
in Bgl II-digested 5¢ dephosphorylated pPuroIRES2 EGFP to
get pT-brap PuroIRES2 EGFP. This was then linearized with
AfeI and electroporated into CGR8 ESC line with 500 lF and
240 V in a Bio-Rad (Munich, Germany) Gene Pulser. The
transfected clones were selected by 400 lg ⁄mL neomycin, and
after selection, the clones were maintained with 200 lg ⁄mL
neomycin.
Confocal fluorescence microscopy
Brachyury-GFP EBs from day 3 to day 5 were washed twice
with prewarmed phosphate buffered saline (PBS) just before
analysis using fluorescence microscopy. EBs suspended in PBS
were analyzed using a confocal microscope (LSM 510 META)
on an inverted stand (Axiovert 200M, Carl-Zeiss, Jena,
Germany) using the objective Plan-NEOFLUAR 10· and the
appropriate filter set for GFP detection. Images were taken
using Zeiss software LSM 5 version 3.5.
Immunohistochemistry
Puromycin-resistant and EGFP-fluorescing brachyury+ cells
obtained, as outlined in Fig. 1d, were plated on the fibronec-
tin coated cover slips. After 24-h post-plating, fixation was
carried out with 99% methanol. Blocking was carried out in
5% bovine serum albumin. Incubations with the primary
antibodies anti-brachyury (Abcam, catalogue ab20680, poly-
clonal, 5 lg ⁄ml) and anti-GFP (Millipore, Billerica, MA,
USA, monoclonal, 1 : 500) were carried out overnight at
4 C in 1% bovine serum albumin. After extensive washing,
secondary detection was carried out for 2 h at room temper-
ature. Hoechst dye (Hoechst 33324, Molecular Probes, Carls-
bad, CA) was used to stain nuclei. Samples were mounted
using ProLong Gold mounting medium (Molecular Probes)
and observed using a Zeiss Axiovert 200 fluorescence micro-
scope.
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Semiquantitative RT-PCR analysis
Total RNA was extracted using RNeasy Mini kit (Qiagen)
with on-column DNase I (Qiagen) digestion according to the
manufacturer’s instructions. Five micrograms of total RNA
was reverse transcribed using SuperScript II Reverse transcrip-
tase (Invitrogen) with random primers according to the manu-
facturer’s recommended protocol. PCR amplification was
carried out using REDTaq ReadyMix (Sigma) with 0.4 lM
each primer. GAPDH was used as an internal control. The fol-
lowing conditions were used: an initial denaturation at 95 C
for 2 min, followed by 22–35 cycles of 30-s denaturation at
95 C, 30 s annealing at 60 C and 60 s of elongation at
72 C. A final extension at 72 C for 5 min was included.
Electrophoretic separation of PCR products was carried out
on 2% agarose gels with 0.001% ethidium bromide. The pri-
mer sequences are listed in the Table S5.
Quantitative real-time PCR
Validation of the Affymetrix data was carried out by qPCR
analysis using ABI Prism 7900HT Sequence Detection System
(Applied Biosystems). An amount of 100 ng RNA each from
every biological triplicate of brachyury ESCs, control EBs and
brachyury+ cells was reverse transcribed using ThermoScript
Reverse Transcriptase (Invitrogen). Then real-time PCR was
carried out in technical triplicates for every sample from three
biologically independent experiments using TaqMan Gene
Expression Assays from Applied Biosystems. The gene expres-
sion assays included for the validation were Sox17
(Mm00488363_m1), Bmp2 (Mm01340178_m1), NF-H
(Mm01191456_m1), GAPDH (Mm99999915_g1) and Nanog
(Mm02019550_s1). The threshold line is set in the exponential
phase of the amplification, and the cycle at which the sample
reaches this level is called the cycle threshold (Ct). Therefore,
the lower the Ct value is the more the gene is expressed.
Averaged Ct values of each qRT-PCR from the target gene
were normalized with the average Ct values of the housekeep-
ing gene, GAPDH, that ran in the same reaction plate to get
DCt value. An increase in DCt value by 1 unit corresponds to
a twofold lowering of the expression level. The fold change
was calculated by using the formula, fold change = 2)(Ct gene1
) Ct gene2). The resulting fold change is expressed as percentage
of the maximum.
Flow cytometry
Single cell suspension was prepared by trypsinization. Cell
clumps were removed by passing through cell strainer cap of a
round bottom tube from Falcon (BD, Heidelberg, Germany).
Propidium iodide (PI) staining (Sigma) was included to
exclude dead cells. Acquisition of 10 000 live (PI negative)
cells was made with FACscan (BD Biosciences), and the data
analysis was carried out with CellQuest software (BD). The
respective wild type EBs on the same day as the sample EBs
were used as the control.
Affymetrix analysis
RNA was extracted from ESCs or EBs using the QIAGEN’s
RNeasy Total RNA Isolation kit. For the synthesis of double-
stranded cDNA from 15 lg total RNA the cDNA synthesis
system kit (Roche, Mannheim, Germany) has been used. Bioti-
nylated cRNA was synthesized with Perkin–Elmer’s nucleotide
analogues using the Ambion’s MEGAScript T7 kit. According
to the standard Affymetrix protocol, 15 lg fragmented cRNA
was hybridized for 16 h at 45 C. RNA preparations from
three biologically independent experiments with three different
conditions (day 0 ES, day 6 control EBs and day 6 puromycin
treated EBs) were processed and hybridized on the Mouse
Genome 430 Version 2 Array (Affymetrix) which includes
45 101 probe sets. After hybridization, arrays were washed and
stained with streptavidin–phycoerythrin in the Affymetrix
GeneChip Fluidics Station 450 and further scanned using the
Affymetrix GeneChip Scanner 3000 7G. The image data were
analyzed with GCOS 1.4 using Affymetrix default analysis
settings and global scaling as normalization method. All chips
passed our quality criteria. Comparability of the experiment
conditions has been checked over all 45 101 probe sets after
RMA normalization (Irizarry et al. 2003) by a principal compo-
nent analysis using Partek Genomic Suite (6.3 beta) correlation
as a dispersion matrix and normalized Eigenvector scaling.
Promoter analysis
The transcription factor binding site analysis was carried out
on the promoters of the genes up-regulated in the brachyury+
cells with the genes up-regulated in BMP-2+ cells and
a-MHC+ cells as reference sets (from our previous work)
(Doss et al. 2007a,b). First, the transcripts up-regulated in the
brachyury+ cells compared to both ESCs and corresponding
EBs were obtained using t-test with significance threshold 0.01
for false discovery rate. The transcripts which were differen-
tially expressed between the ESCs and EBs were discarded.
The same procedure was repeated for BMP-2+ and a-MHC+
cells to obtain the BMP-2+ and a-MHC+-specific transcript
lists. After mapping transcripts to genes and discarding 200
genes contained in more than one list, we had 105 genes in
brachyury+-specific list, 266 genes in BMP-2+-specific list and
584 genes in a-MHC+-specific list. The promoters of these
genes were compared against each other with respect to tran-
scription factor binding sites. For the source of binding motifs,
we used the position weight matrices (PWMs) from Transfac
(version 11.4) (Wingender et al. 1996) and Jaspar (Sandelin
et al. 2004) databases. Promoters of size 2-kb upstream of the
transcription start site were obtained from the UCSC Genome
Browser database (Karolchik et al. 2008). In case two promot-
ers of the same gene had overlapped more than 1 kb, we dis-
carded one of the promoters. Each PWM was scored in every
promoter by taking the average of the three highest scoring
hits within the promoter. A PWM was considered interesting
if the proportion of promoters scoring over some threshold
was significantly higher in the brachyury+ list than in the other
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two lists combined. The threshold was optimized for the fold
change in the proportion, while requiring the Bonferroni cor-
rected hypergeometric P-value to be below 0.05.
Functional annotation
Differentially expressed genes were analyzed according to pre-
defined pathways and functional categories annotated by
KEGG (Kanehisa & Goto 2000), BioCarta (BioCarta Pathways
2009) and GO using the DAVID bioinformatic resource (Den-
nis et al. 2003). For an overrepresented GO or KEGG path-
way, a cutoff P-value of 0.01 has been chosen. In general, it
should be noted that one gene can participate in more than
one KEGG or BioCarta pathway and GO category.
siRNA knockdown
ON-TARGET plus Smart pool siRNA against Larp2 was pur-
chased from Thermo Scientific Dharmacon, Lafayette, CO,
USA. siRNA targeted against Anrd34b was purchased from
Qiagen Inc. (Cat. no. SI00864199, against the target sequence
ACGGAACAAATTAAGCAATTA). Brachyury ESCs or wild
type cells (each 1 · 105 per well of 12-well plate) were cul-
tured for 24 h before incubating with 100 nm siRNA and
1.0 lL Lipofectamine 2000 (Invitrogen) for optimal transfec-
tion Nontarget control siRNA was used as negative control
for each assay. Hanging drop EBs were made 48 h post-
siRNA transfection. EBs were harvested at regular daily inter-
vals from day 0 to day 10, and the transcripts of interest were
analyzed at the mRNA level by qRT-PCR.
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The following Supporting Information can be found in the
online version of the article:
Figure S1 Overview of the Bacterial Artificial Chromosomes
(BAC) subcloning by recombineering approach (right scheme,
slightly modified from the Gene Bridges BAC recommbineer-
ing manual) to subclone the brachyury promoter from the
BAC and then to clone the promoter into Puro ⁄EGFP IRES
vector.
Figure S2 Validation of Affymetrix data by quantitative real-
time polymerase chain reaction (PCR) analyses. The fold
change was calculated by using the formula: fold-chan-
ge = 2)(DCtgene1 ) DCtgene2). DCt of the gene in the sample in
which it is expressed lowest is taken as DCt gene2 to calculate
the fold change using the above formula. The resulting fold
change is expressed as percentage of the maximum fold change
(= 100%) for that particular gene in every assay. Values are
expressed as mean ± standard deviation (n = 3; technical repli-
cates).
Transcriptome of brachyury+ (T) cells
 2010 The Authors Genes to Cells (2010) 15, 209–228
Journal compilation  2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.
227
Figure S3 Hierarchical clustering of the transcripts up- or
downregulated in brachyury+ cells in comparison to at least
one of brachyury ESCs and the 6-days old control EBs.
Figure S4 RT-PCR analysis for various developmental gene
markers in ESCs and EBs treated with either siRNA against
Ankrd34b or with vehicle of the siRNA.
Table S1 Transcription factors (a) and development related
(b) transcripts upregulated in brachyury+ cells compared to
both undifferentiated brachyury ESCs and control 6-days old
brachyury EBs
Table S2 Development (a), transcription factors (b) and signal
transducers (c) related transcripts upregulated in brachyury+
cells compared to undifferentiated brachyury ESCs but down-
regulated in comparison to the 6-days old EBs
Table S3 Development (a), transcription factors (b) and signal
transducers (c) related transcripts upregulated in brachyury+
cells compared to control 6 day EBs but downregulated in
comparison to the brachyury ESCs
Table S4 Development (a), transcription factors (b) and signal
transducers (c) related transcripts upregulated in brachyury+
cells compared to either control 6 day EBs or to the brachyury
ESCls but which don’t show any twofold downregulation than
anyone of the control population
Table S5 Primers and conditions used in this study for the
semiquantitative PCR analysis
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